γ-Aminobutyric acid receptor alpha 1 subunit loss of function causes genetic generalized epilepsy by impairing inhibitory network neurodevelopment
Autor: | Eric Samarut, Patrick Cossette, Liselotte Dufour, Marc Allard, Nadia Soussi-Yanicostas, Solène Renault, Rahma Hassan-Abdi, Pierre Drapeau, Amrutha Swaminathan, Meijiang Liao, Raphaëlle Riché |
---|---|
Přispěvatelé: | Department of Neurosciences [Montréal, QC, Canada], Université de Montréal (UdeM)-Centre Hospitalier de l'Université de Montréal (CHUM), Université de Montréal (UdeM), Molecular Biology and Genetics Unit [Bangalore, India] (Transcription and Disease Laboratory), Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR)-Indian Institute of Science, Neuroprotection du Cerveau en Développement / Promoting Research Oriented Towards Early Cns Therapies (PROTECT), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Robert Debré-Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier de l'Université de Montréal (CHUM), Maladies neurodéveloppementales et neurovasculaires (NeuroDiderot (UMR_S_1141 / U1141)), Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CR CHUM), Université de Montréal (UdeM)-Université de Montréal (UdeM), Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Hôpital Robert Debré-Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Diderot - Paris 7 (UPD7), Centre de recherche du Chum [Montréal] (CRCHUM) |
Jazyk: | angličtina |
Rok vydání: | 2018 |
Předmět: |
0301 basic medicine
Embryo Nonmammalian Light [SDV]Life Sciences [q-bio] Green Fluorescent Proteins Gene Expression [SDV.BC]Life Sciences [q-bio]/Cellular Biology Inhibitory postsynaptic potential Epileptogenesis Clonazepam Animals Genetically Modified Gabra1 loss of function 03 medical and health sciences Epilepsy 0302 clinical medicine medicine Anti-epileptic drugs Animals MESH: Epilepsy Gabra1 loss of function Zebrafish High‐throughput antiepileptic drug screening Anti-epileptic drugs [SDV.BBM]Life Sciences [q-bio]/Biochemistry Molecular Biology Generalized epilepsy Zebrafish Loss function Neurons biology Glutamate Decarboxylase Mortality Premature Brain Gene Expression Regulation Developmental medicine.disease biology.organism_classification Receptors GABA-A High‐throughput antiepileptic drug screening Disease Models Animal 030104 developmental biology Neurology Neurodevelopmental Disorders Larva Mutation GABAergic Axon guidance Anticonvulsants Epilepsy Generalized Neurology (clinical) Transcriptome Neuroscience 030217 neurology & neurosurgery |
Zdroj: | Epilepsia Epilepsia, Wiley, 2018, 59 (11), pp.2061-2074. ⟨10.1111/epi.14576⟩ |
ISSN: | 0013-9580 |
DOI: | 10.1111/epi.14576⟩ |
Popis: | International audience; Objective: In humans, mutations of the γ-aminobutyric acid receptor subunit 1 (GABRA1) cause either mild or severe generalized epilepsy. Although these epilepsy causing mutations have been shown to disrupt the receptor activity in vitro, their in vivo consequences on brain development and activity are not known. Here, we aim at unraveling the epileptogenesis mechanisms of GABRA1 loss of function. Methods: We generated a gabra1 −/− zebrafish mutant line displaying highly pen-etrant epileptic seizures. We sought to identify the underlying molecular mechanisms through unbiased whole transcriptomic assay of gabra1 −/− larval brains. Results: Interestingly, mutant fish show fully penetrant seizures at juvenile stages that accurately mimic tonic-clonic generalized seizures observed in patients. Moreover , highly penetrant seizures can be induced by light stimulation, thus providing us with the first zebrafish model in which evident epileptic seizures can be induced by nonchemical agents. Our transcriptomic assay identified misregulated genes in several pathways essential for correct brain development. More specifically, we show that the early development of the brain inhibitory network is specifically affected. Although the number of GABAergic neurons is not altered, we observed a drastic reduction in the number of inhibitory synapses and a decreased complexity of the GABAergic network. This is consistent with the disruption in expression of many genes involved in axon guidance and synapse formation. Significance: Together with the role of GABA in neurodevelopment, our data identify a novel aspect of epileptogenesis, suggesting that the substratum of GABRA1-deficiency epilepsy is a consequence of early brain neurodevelopmental defects, in particular at the level of inhibitory network wiring.This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
Databáze: | OpenAIRE |
Externí odkaz: |